Subscribe to RSS
DOI: 10.1055/s-2008-1078716
© Georg Thieme Verlag KG Stuttgart · New York
WNT-4 mRNA Expression in Human Adrenocortical Tumors and Cultured Adrenal Cells
Publication History
received 06.08.2007
accepted 14.02.2008
Publication Date:
13 June 2008 (online)
Abstract
The members of the Wnt glycoprotein family are important in embryogenesis and adult tissue homeostasis, and deletion of Wnt-4 gene in mice leads to improper development of many organs including the adrenals. The objective of this study was to investigate the expression of WNT-4 gene in human adrenals and adrenocortical tumors. The WNT-4 mRNA expression (analyzed by quantitative real-time RT-PCR) was significantly higher in Conn's adenomas (p<0.01) and lower in Cushing's adenomas, virilizing carcinomas and fetal adrenals (p<0.05) compared with normal adult adrenals. WNT-4 mRNA expression was clearly upregulated by ACTH and 8-bromo-cAMP (8-BrcAMP) in primary cultures of normal adult adrenocortical cells, but downregulated by 8-BrcAMP and 12-O-tetradecanoylphorbol-13-acetate (TPA) in human NCI-H295R adrenocortical carcinoma cells. Angiotensin II tended to increase WNT-4 mRNA expression at 24 hours and decreased it at 48 hours time point in both cell culture types. The abundant WNT-4 mRNA expression in Conn's adenomas and its hormonal regulation in adrenocortical cells suggest a role for WNT-4 in human adrenocortical function.
Key words
WNT-4 - adrenal glands - β-catenin - adrenal cortex - neoplasms (human)
References
- 1 Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20 781-810
- 2 Dale TC. Signal transduction by the Wnt family of ligands. Biochem J. 1998; 329 209-223
- 3 Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003; 116 2627-2634
- 4 Huelsken J, Behrens J. The Wnt signalling pathway. J Cell Sci. 2002; 115 3977-3978
- 5 Miller JR. The Wnts. Genome Biol. 2002; 3 , reviews 3001.1–3001.15
- 6 Moon RT, Kohn AD, Ferrari GV De, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5 691-701
- 7 Vainio S, Heikkilä M, Kispert A, Chin N, MacMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999; 397 405-409
- 8 Bernard P, Harley VR. Wnt4 action in gonadal development and sex determination. Int J Biochem Cell Biol. 2007; 39 31-43
- 9 Mizusaki H, Kawabe K, Mukai T, Ariyoshi E, Kasahara M, Yoshioka H, Swain A, Morohashi K. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Mol Endocrinol. 2003; 17 507-519
- 10 Heikkilä M, Prunskaite R, Naillat F, Itäranta P, Vuoristo J, Leppäluoto J, Peltoketo H, Vainio S. The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology. 2005; 146 4016-4023
- 11 Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad Sci USA. 2003; 100 10866-10871
- 12 Jeays-Ward K, Dandonneau M, Swain A. Wnt4 is required for proper male as well as female sexual development. Dev Biol. 2004; 276 431-440
- 13 Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet. 2001; 68 1102-1109
- 14 Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med. 2004; 351 792-798
- 15 Suwa T, Chen M, Hawks CL, Hornsby PJ. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. J Endocrinol. 2003; 178 149-158
- 16 Peltoketo H, Allinen M, Vuosku J, Kujala S, Lundan T, Salminen A, Winqvist R, Vainio S. Characterization and expression of the human WNT4; lack of associated germline mutations in high-to moderate-risk breast and ovarian cancer. Cancer Lett. 2004; 213 83-90
- 17 Heikkilä M, Peltoketo H, Leppäluoto J, Ilves M, Vuolteenaho O, Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology. 2002; 143 4358-4365
- 18 Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R, Kahri AI. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol. 2000; 165 223-229
- 19 Voutilainen R, Erämaa M, Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab. 1991; 73 1026-1030
- 20 Vänttinen T, Kuulasmaa T, Liu J, Voutilainen R. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J Clin Endocrinol Metab. 2002; 87 4257-4263
- 21 Utriainen P, Liu J, Kuulasmaa T, Voutilainen R. Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R. J Endocrinol. 2006; 188 305-310
- 22 Eberhart CG, Argani P. Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatr Dev Pathol. 2001; 4 351-357
- 23 Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC, Barth AM, McCrea PD. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res. 2004; 298 369-387
- 24 Hou X, Tan Y, Li M, Dey SK, Das SK. Canonical Wnt signaling is critical to estrogen-mediated uterine growth. Mol Endocrinol. 2004; 18 3035-3049
- 25 Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005; 65 7622-7627
- 26 Chen M, Hornsby PJ. Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells. Horm Metab Res. 2006; 38 549-555
Correspondence
R. Voutilainen
Department of Pediatrics
Kuopio University Hospital
P.O. Box 1777
70211 Kuopio
Finland
Phone: +358/17/17 23 91
Fax: +358/17/17 24 10
Email: Raimo.Voutilainen@uku.fi